Home›Companies›Biotech & Pharma›Palimpsest Bio

Palimpsest Bio Corp.

No website or LinkedIn page we could confirm. Why?
Updated Nov 4, 2026·Latest SEC filing Oct 30, 2026·Suggest an edit

About Palimpsest Bio

Palimpsest Bio is a private company based in Las Vegas, Nevada, incorporated in 2026 in Delaware. It has reported $172,000 raised in one offering on Form D since October 2026. Its chief executive is Matthew Korpela.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 27, 2026Oct 30, 2026$172,000of $1.0M target4$43,000Simple Agreement for Future Equity (SAFE)Rule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Palimpsest Bio's Form D filed Oct 30, 2026.

MK
Matthew Korpela
Chief Executive Officer and director

Sources

  1. SECPalimpsest Bio Corp. filing history